Clyde Biosciences (Group)

https://www.clydebio.com

Clyde Biosciences provides the gold standard in cardiac cell function assessment for pre-clinical pharmaceutical R&D, safety pharmacology and cardiac drug development. Clyde provides early identification of cardiotoxicity in small molecule drug candidates using its CellOPTIQ® HCA to boost its partners’ chances of success. Detecting small molecule cardiotoxicity late in the drug development process wastes time and money. Most seriously, it reduces the success rate in bringing new drug candidates through to clinical studies. CellOPTIQ® HCA is a completely new type of cardiac cell function assay that guarantees clear, accurate assessment of the dose-dependent effects of any drug or combination of drugs. Clyde Biosciences is trusted by world-leading biopharma companies and academic centres to deliver precise cardiac cell function assessment which can be used to determine drug efficacy and safety. *

	Start	2018-09-27 existent
	Industry	cell-based assay (research)
	Industry 2	CellOptiq® High Content Assay (HCA)

	Street	Bo’Ness Road BioCity Scotland
	City	ML1 5UH Newhouse, Lanarkshire
	Tel	+44-1698-539920
		Address record changed: 2020-12-02

Basic data	Employees	n. a.

		* Document for »About Section«: Clyde Biosciences Ltd.. (9/27/18). "Press Release: Major International FDA-led Study Confirms CellOptiq High Content Assay as Leading in vitro Platform to Assess Cardiotoxicity in New Drugs". Motherwell.

		Record changed: 2023-07-10

Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x200px

More documents for Clyde Biosciences (Group)

[1] Clyde Biosciences Ltd.. (9/27/18). "Press Release: Major International FDA-led Study Confirms CellOptiq High Content Assay as Leading in vitro Platform to Assess Cardiotoxicity in New Drugs". Motherwell....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]